Storify of Tuesday's TwitterChat

Tejas Desai of Nephrology On-Demand curated the chat into a tight Storify.

NephJC #9 is in the can

Great tweet chat tonight. Here are the analytics and the transcript. Look for a curated (Storify) transcript in a day or two.

Tweet of the (last) Week

Every so often a single tweet neatly encompasses the entire discussion. This happened at last week's aPLA2R TweetChat. This is the tweet that won:

@NephJC #nephjc We've got our viral load for IMN methinks

— ChristosArgyropoulos (@ChristosArgyrop) August 13, 2014

But to properly set it up you need to additional tweets:

@NephJC @ChristosArgyrop Clinical response delayed for months after Ab decline.Not sure when to stop unless following a protocol. #nephjc

— Ross Morton (@signindoc) August 13, 2014

@signindoc @NephJC Exactly #nephjc Would need protocol similar to what the HIV guys did: PLA2R is viral load, proteinuria=CD4+immune fx

— ChristosArgyropoulos (@ChristosArgyrop) August 13, 2014

I love the idea of aPLA2R as a viral load, a leading indicator of idiopathic membranous nephropathy. Nice work Christos. For your effort we will be sending you a #NephJC coffee mug.

Want your own NephJC coffee mug?

Tweet better!

Next opportunity is tonight 9pm Eastern.

The Storify overview of #NephJC 8: aPLA2R

Once again we have two curated archives of the discussion. Joel Topf just published his version for NephJC:

And Tejas of Nephrology On-Demand once again published his curation:

aPLA2R Tweetchat, by the numbers

The August 12 Tweetchat went well with broad participation.

Tonight's NephJC Tweetchat is all about aPLA2R

aPLA2R is the first blood test specifically for nephrotic syndrome. It has recently been licensed by the FDA and we want to have an open and frank discussion on how this test may be used in clinical medicine. To aid in this discussion we will be looking at two papers.

The first was highlighted by CJASN's eJC and was covered summarized by Joel Topf and his Fellow, Bilal Saleem:

• Article Association of Anti-PLA2R Antibodies with Outcomes after Immunosuppressive Therapy in Idiopathic Membranous Nephropathy
• eJC forum
•  Background and Summary by Topf and Saleem
• Make sure you take a look at the Editorial by Glassock (available for free if you register with eJC)
• PDF slide show summary of the article and editorial

The second article was published this past Spring in NDT. It is an industry sponsored trial of ACTH for the treatment of membranous nephropathy. Swapnil Hiremath summarized it for #NephJC

• Article (#OpenAccess)
• Background by Hiremath
• PDF of summary

And additionally here is a link to the KDIGO Glomerulonephritis Recommendations.

Please join us on Twitter at 9pm Eastern Daylight. Use the hashtag #NephJC.

FOAMED Student blog covers Nephrology

The Foamed Student blog, run by medical students (@intransition2 and friends) down under - recently covered nephrology FOAMED resources, including our efforts, and others. Thanks, guys! 

Pubmed Commons comment up for Meso-American Nephropathy

A bit belatedly, the pubmed comment is up from the great discussion from July 8th on MesoAmerican Nephropathy here.